【摘 要】
：
Cancer therapy drugs face various transportation barriers in transit to the tumor site,making the delivery of effective drug concentrations problematic1.Moreover,these drugs are difficult to use due t
【机 构】
：
Institute of Nano Biomedicine and Engineering,Key Laboratory for Thin Film and Microfabrication Tech
【出 处】
：
第三届国际纳米药物大会 ChinaNanomedicine 2018 The 3rd International Con
论文部分内容阅读
Cancer therapy drugs face various transportation barriers in transit to the tumor site,making the delivery of effective drug concentrations problematic1.Moreover,these drugs are difficult to use due to their adverse off-target effects2,3.
其他文献
As the largest biological filtration system in body,liver sequesters the majority of administered nanomedicines and causes low drug delivery efficiency to diseased tissue,which prevents the clinical t
Size and shape are fundamental properties of polymeric nanomedicine that determine its efficacy.Unlike size effect been well-studied,the impact of particle shape remains vaguely understood.1 In partic
Protein drugs are widely explored to prevent or treat chronic or inflammatory diseases and cancers because of their significant advantages in high specificity and function.However,therapeutic proteins
The development of multidrug resistance(MDR)in cancer remains one of the major causes for therapeutic treatment failure in clinic.Herein,mechanistic studies of a high-performing dual-drugs loaded poly
Polylactones like poly(L-lactide)(PLLA),poly(lactic-co-glycolic acid)(PLGA),poly(caprolactone)(PCL),and their PEG block derivatives,approved by the FDA for use,are the most popular biodegradable and b
The therapeutic performance of anti-cancer nanomedicine is greatly challenged by the low drug loading and tumor targeting.To overcome these issues,we first developed micelles with high drug loading an
We report a new methodology for the synthesis of polymer-drug conjugates that are designed to self-assemble into nanoparticles and release drug in response to a physiologically relevant stimulus from
Stimuli-responsive polycations have been developed for ondemond nucleic acid and protein delivery for cancer therapy1.Among all of the responsive triggers,ATP shows great potential in controlling the
Multi-walled carbon nanotubes(MWCNTs)-induced lung fibrosis leads to health concerns in human.However,little is known about the mechanisms underlying fibrosis pathogenesis.
Among the thiolate protected gold nanoclusters(GNCs),chiral glutathione(i.e.GSH; γ-Glu-Cys-Gly),a naturally occurring and readily available tripeptide,has been commonly used as a monolayer thiolate li